CSF monoamine metabolites in schizophrenic patients
- PMID: 6184954
- DOI: 10.1111/j.1600-0447.1982.tb06717.x
CSF monoamine metabolites in schizophrenic patients
Abstract
The monoamine metabolites 3-methoxy-4-hydroxyphenyglycol (MHPG), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were measured in the cerebrospinal fluid (CSF) of 16 psychiatrically health controls and in 28 schizophrenic patients. There was no difference in CSF MHPG and HVA levels between the group of patients and the controls. CSF levels of 5-HIAA were significantly lower in schizophrenic patients than in controls. Differential analysis of patients with and without neuroleptics revealed that these findings were not due to drug treatment. Positive correlations were found between the level of 5-HIAA and the items: hallucinatory behaviour, grandiosity, and tension as rated on the Brief Psychiatric Rating Scale. As 5-HIAA CSF data are controversial for nosological entities, the search for correlations between 5-HIAA and individual psychopathological variables could provide more specific indices for psychiatric diagnosis, treatment or prophylaxis.
Similar articles
-
CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.Psychol Med. 1985 May;15(2):335-40. doi: 10.1017/s0033291700023618. Psychol Med. 1985. PMID: 2410941
-
Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.Arch Gen Psychiatry. 1993 Aug;50(8):606-14. doi: 10.1001/archpsyc.1993.01820200016002. Arch Gen Psychiatry. 1993. PMID: 7688209
-
Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.Arch Gen Psychiatry. 1980 Oct;37(10):1113-6. doi: 10.1001/archpsyc.1980.01780230031004. Arch Gen Psychiatry. 1980. PMID: 6158928
-
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?Med Biol. 1985;63(1):1-17. Med Biol. 1985. PMID: 2582215 Review.
-
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.Brain Res. 1974 Oct 11;79(1):1-8. doi: 10.1016/0006-8993(74)90562-9. Brain Res. 1974. PMID: 4279131 Review. No abstract available.
Cited by
-
The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.Psychopharmacology (Berl). 1993;112(1 Suppl):S5-15. doi: 10.1007/BF02245003. Psychopharmacology (Berl). 1993. PMID: 7831440 Review.
-
Clozapine pharmacology and tardive dyskinesia.Psychopharmacology (Berl). 1989;99 Suppl:S54-9. doi: 10.1007/BF00442560. Psychopharmacology (Berl). 1989. PMID: 2479047
-
Theranostic Biomarkers for Schizophrenia.Int J Mol Sci. 2017 Mar 30;18(4):733. doi: 10.3390/ijms18040733. Int J Mol Sci. 2017. PMID: 28358316 Free PMC article. Review.
-
Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.J Neural Transm. 1983;57(1-2):103-10. doi: 10.1007/BF01250052. J Neural Transm. 1983. PMID: 6194254
-
Marine Bacterial Compounds Evaluated by In Silico Studies as Antipsychotic Drugs Against Schizophrenia.Mar Biotechnol (NY). 2018 Oct;20(5):639-653. doi: 10.1007/s10126-018-9835-3. Epub 2018 Jul 18. Mar Biotechnol (NY). 2018. PMID: 30019186
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials